SKF 87516J
Alternative Names: SKF 87516Latest Information Update: 20 Nov 1996
At a glance
- Originator Unknown
- Developer GlaxoSmithKline
- Class Heart failure therapies; Vasodilators
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure